Quality Premium
What are the mechanisms and mediators of a high-cost health-system level intervention, the 'antibiotic prescribing quality premium'?
In this workstream our objectives are to:
- Identify what contextual factors and intervention components are assocaited with more successful implementationof the 'antibiotic prescribing quality premium' at clinical commissioning group level, in terms of reducing antibiotic prescribing.
- Estimate the cost-effectiveness of the 'quality premium' in reducing prescribing, both using standard methods and novel methods developed within this programme